A modified version of the CRISPR/Cas9 tool could be used to track RNA in live cells using a method known as RNA-targeting Cas9. This, in turn, could be used to cure ALS and Huntington's disease.
NYS Entity Status
NYS Filing Date
OCTOBER 01, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2014 - MODERN AIR INNOVATIONS INC.
Around the Web
- New CRISPR technique could accelerate a cure for Huntington's disease and ALS
By Lulu Chang - Monday Aug 14, 2017
- ‘Lost Tapes: Son of Sam’ explores grim time in N.Y.
By David Bauder - Friday Jul 28, 2017
NEW YORK — Geraldo Rivera dates the low point in modern New York City history to Aug. 9, 1977. That was the day before police arrested David Berkowitz, the serial killer who called himself “Son of Sam.” He terrorized the city for a year with late-night shootings, killing six and wounding seven, and primarily targeted young women sitting in cars. The time is vividly brought to life in the Smithsonian Channel documentary, “The Lost Tapes: Son of Sam,” premiering Sunday at 9 p.m. The Investigation Discovery network is airing its own retrospective on the crime spree that airs next Saturday, Aug. 5.
- Does Electroconvulsive Therapy Improve Huntington’s Disease?
Wednesday Jul 19, 2017
For over 70 years Electroconvulsive Therapy (ECT) has been used to treat severe depression and there are reports that it could help patients with Huntington’s Disease who experience psychiatric symptoms. Many patients with Huntington’s Disease experience depression, with suicide rates 5 to 10 times higher than the general public. In 21 published case reports where -
- MSH3 Gene Reveals Critical Link With Huntington’s Disease
Wednesday Aug 9, 2017
A recent study published in Lancet Neurology reveals important associations between MSH3 gene mutations and Huntington’s disease progression and disease burden.
- The Link Between Huntington’s Disease and Brain Structure
Wednesday Sep 6, 2017
Scientists at Northwestern University have discovered a link between Huntington’s Disease and dysfunction of the brain’s structure. These finding may explain the causes of the debilitating symptoms and loss of brain tissue as the disease progresses. Currently, it is not understood why the mutation of a specific gene leads to expression of symptoms and loss -